Satyajit Kosuri

NPI 1306028451ActiveIndividual· Internal Medicine, Hematology & Oncology· Chicago, IL

Internal Medicine, Hematology & Oncology with University of Chicago and 1 other group, practicing in Chicago, Illinois. Their prescriptions cost Medicare Part D more than their services did: $1,383,838 for 112 claims, against $47,836 paid for services in 2024. Incyte Corporation was the largest of 2 companies reporting payments in 2025, $3,379 in all, mostly consulting fees. Lists The University of Chicago Medical Center as a hospital affiliation.

Overview

NPI	1306028451
Status	Active
Entity type	Individual
Sole proprietor	No
NPI issued	Nov 30, 2007
Last updated in NPPES	Oct 24, 2022

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Hematology & Oncology Primary	207RH0003X	036141656	IL

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Oct 9, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026	No match	—
New York OMIG · Nov 10, 2026	No match	—
Ohio Medicaid · Nov 10, 2026	No match	—
Pennsylvania Medicheck · Nov 10, 2026	No match	—
Washington HCA · Nov 10, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematopoietic Cell Transplantation and Cellular Therapy (IL)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	87
Services billed	488 across 14 procedure codes
Paid by Medicare	$47,836

Part D prescriptions in 2024

Prescriptions (claims)	112 · 115 30-day fills
Patients	19
Total drug cost	$1,383,838
Generic share	30% of claims

Medicare sources and data years

Education and affiliations

Graduation year	2007
Medicare specialty	Hematopoietic Cell Transplantation And Cellular Therapy
Secondary specialties	Hematology/Oncology
Telehealth	Offers telehealth